New drug ADCE-B05 targets Hard-to-Treat cancers in early trial
NCT ID NCT07362888
First seen Jan 27, 2026 · Last updated May 22, 2026 · Updated 25 times
Summary
This early-phase study tests a new drug called ADCE-B05 in people with advanced solid tumors that have not responded to standard treatments. The main goals are to find the safest dose and check for side effects. About 180 participants will receive the drug to see how well it is tolerated and how the body processes it.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOLID TUMORS (PHASE 1) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Highlands Oncology Group
RECRUITINGSpringdale, Arkansas, 72762, United States
-
Monash Health
NOT_YET_RECRUITINGClayton, South Australia, 3165, Australia
-
Peter MacCallum Cancer Centre
NOT_YET_RECRUITINGMelbourne, Victoria, 3000, Australia
-
Scientia Clinical Research
RECRUITINGRandwick, New South Wales, 2031, Australia
-
Southern Oncology Clinical Research Unit
RECRUITINGBedford Park, South Australia, 5042, Australia
-
University Of Texas MD Anderson Cancer Center
RECRUITINGHouston, Texas, 77030, United States
-
Yale University
NOT_YET_RECRUITINGNew Haven, Connecticut, 06520, United States
Conditions
Explore the condition pages connected to this study.